OneMedNet inks deal with top medical device leader for real-world data services.
ByAinvest
Monday, Aug 25, 2025 7:58 am ET1min read
ONMD--
The collaboration leverages OneMedNet's extensive iRWD™ network, which spans over 1,750 provider sites. The company has already begun fulfilling these recent orders, demonstrating its efficient execution capabilities in providing curated, de-identified, and fit-for-purpose datasets for AI development, clinical trial enhancement, and healthcare outcome improvement [1].
OneMedNet's announcement represents a significant commercial expansion with one of healthcare's most influential players. The evergreen master services agreement is particularly valuable as it establishes an ongoing revenue relationship without a fixed termination date, reducing customer acquisition costs and providing greater revenue predictability [1].
The four separate purchase orders indicate diverse use cases for OneMedNet's real-world data, suggesting their platform has multiple applications within a single organization. This demonstrates product versatility and increases potential wallet share from each customer. The immediate commencement of delivery on these orders confirms operational readiness and suggests near-term revenue recognition [1].
What truly differentiates OneMedNet in the competitive healthcare data landscape is their multimodal data offering. By combining advanced medical imaging with comprehensive patient histories and clinical notes, they're delivering the contextual richness necessary for developing sophisticated AI models. This comprehensive approach addresses a critical challenge in healthcare AI development—the need for diverse, interconnected data types that reflect real-world clinical scenarios [1].
The company's network spanning 1,750+ provider sites represents a substantial competitive moat. Building such extensive provider relationships requires significant time investment and regulatory navigation, creating barriers to entry for competitors. The emphasis on regulatory-grade data quality further strengthens their market position, particularly for customers developing products requiring FDA or other regulatory approvals [1].
The partnership underscores OneMedNet's ability to deliver high-quality, diverse data sets that meet the rigorous standards demanded by leading healthcare brands. This collaboration is expected to drive further innovation in medical imaging AI and contribute to improved patient outcomes [1].
References:
[1] https://www.stocktitan.net/news/ONMD/one-med-net-expands-multiple-revenue-delivering-projects-under-4mphg3ibu805.html
OneMedNet Corporation, a leader in AI-powered Real-World Data, has announced significant adoption by one of the world's top five medical device leaders. The company has entered into a master services agreement with a renowned medical device innovator, providing for an evergreen engagement with no fixed term. The agreement includes four distinct purchase orders for OneMedNet's Real-World Data, focused on delivering diverse, regulatory-grade multi-modal data to accelerate innovation in medical imaging AI model development.
OneMedNet Corporation (Nasdaq:ONMD), a leading provider of AI-powered Real-World Data (RWD), has announced a significant expansion in its partnership with one of the world's top five medical device companies. The company has entered into a master services agreement with the renowned innovator, providing for an evergreen engagement with no fixed term. This agreement includes four distinct purchase orders for OneMedNet's RWD, focused on delivering diverse, regulatory-grade multi-modal data to accelerate innovation in medical imaging AI model development [1].The collaboration leverages OneMedNet's extensive iRWD™ network, which spans over 1,750 provider sites. The company has already begun fulfilling these recent orders, demonstrating its efficient execution capabilities in providing curated, de-identified, and fit-for-purpose datasets for AI development, clinical trial enhancement, and healthcare outcome improvement [1].
OneMedNet's announcement represents a significant commercial expansion with one of healthcare's most influential players. The evergreen master services agreement is particularly valuable as it establishes an ongoing revenue relationship without a fixed termination date, reducing customer acquisition costs and providing greater revenue predictability [1].
The four separate purchase orders indicate diverse use cases for OneMedNet's real-world data, suggesting their platform has multiple applications within a single organization. This demonstrates product versatility and increases potential wallet share from each customer. The immediate commencement of delivery on these orders confirms operational readiness and suggests near-term revenue recognition [1].
What truly differentiates OneMedNet in the competitive healthcare data landscape is their multimodal data offering. By combining advanced medical imaging with comprehensive patient histories and clinical notes, they're delivering the contextual richness necessary for developing sophisticated AI models. This comprehensive approach addresses a critical challenge in healthcare AI development—the need for diverse, interconnected data types that reflect real-world clinical scenarios [1].
The company's network spanning 1,750+ provider sites represents a substantial competitive moat. Building such extensive provider relationships requires significant time investment and regulatory navigation, creating barriers to entry for competitors. The emphasis on regulatory-grade data quality further strengthens their market position, particularly for customers developing products requiring FDA or other regulatory approvals [1].
The partnership underscores OneMedNet's ability to deliver high-quality, diverse data sets that meet the rigorous standards demanded by leading healthcare brands. This collaboration is expected to drive further innovation in medical imaging AI and contribute to improved patient outcomes [1].
References:
[1] https://www.stocktitan.net/news/ONMD/one-med-net-expands-multiple-revenue-delivering-projects-under-4mphg3ibu805.html
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet